No Data
No Data
Carnegie Group Upgrades AstraZeneca to Buy, Lifts PT
Allurion (ALUR.US) stock price surged violently; its new weight loss therapy can maintain muscle mass.
On Thursday, Allurion's stock price soared 80% in after-hours trading, following reports that the company plans to conduct clinical research combining its gastric balloon weight loss product with GLP-1 drugs.
Allurion Stock Soars 70% on Weight-loss Therapy Update
AstraZeneca to Invest C$820 Million to Move to Larger Toronto Office
Astrazeneca Announces A $570M Investment In Canada, Creating More Than 700 High-Skilled Jobs
Why Is AstraZeneca PLC (AZN) Among the Best Large-Cap Value Stocks to Buy in 2025?
loading...
Growth Investor27 : I own a lot & will buy more
DazzlerAus : agree but nothing seems to help
Youngman : I keep hearing nothing but good things about the stock while it goes down lol